Aktuelle Evidenz zum standardisierten Vorgehen bei RSV-Infektionen von Neugeborenen, Säuglingen und Kleinkindern

Das Respiratory Syncytial Virus (RSV) ist das meistidentifizierte Pathogen, das akute Infektionen der unteren Atemwege auslöst. Es gehört zu den führenden Ursachen für Morbidität und Mortalität bei Kindern unter fünf Jahren [1]. Dies führt jährlich zu einer hohen Hospitalisierungsrate und dadurch zu einer Überlastung der Gesundheitssysteme [2]. Obwohl diverse Leitlinien die empfohlene Vorgehensweise für die stationäre Versorgung beschreiben, werden Interventionen entgegen der vorliegenden Evidenz durchgeführt. Zudem fehlt es an einer Standardisierung von Erkennung und Überwachung einer RSV-Infektion, an allgemein zugänglichen Informationen und an effizienten Prophylaxestrategien [3].

Publication History

Article published online:
06 August 2025

• Literatur

• 1 Liu L, Oza S, Hogan D. et al Global, regional, and national causes of under-5 mortality in 2000–15: An updated systematic analysis with implications for the Sustainable Development Goals. Lancet 2016; 388: 3027-3035
• 2 Duan Y, Jiang M, Huang Q. et al Incidence, hospitalization, and mortality in children aged 5 years and younger with respiratory syncytial virus-related diseases: A systematic review and meta-analysis. Influenza Other Respir Viruses 2023; 17: e13145
• 3 Griffiths C, Drews SJ, Marchant DJ.. Respiratory syncytial virus: Infection, detection, and new options for prevention and treatment. Clin Microbiol Rev 2017; 30: 277-319
• 4 Iwane MK, Farnon EC, Gerber SI.. Importance of global surveillance for respiratory syncytial virus. J Infect Dis 2013; 208 Suppl 3 S165-6
• 5 Li Y, Wang X, Blau DM. et al Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: A systematic analysis. Lancet 2022; 399: 2047-2064
• 6 Di Carlo P, Romano A, Plano MRA. et al Children, parents and respiratory syncytial virus in Palermo, Italy: Prevention is primary. J Child Health Care 2010; 14: 396-407
• 7 Ostadabbas S, Bulach C, Ku DN. et al A passive quantitative measurement of airway resistance using depth data. Annu Int Conf IEEE Eng Med Biol Soc 2014; 2014: 5743-5747
• 8 Shi T, Vennard S, Mahdy S. et al Risk factors for poor outcome or death in young children with respiratory syncytial virus-associated acute lower respiratory tract infection: A systematic review and meta-analysis. J Infect Dis 2022; 226: S10-S16
• 9 Dachverband der Sozialversicherungsträger. Sari-Dashboard. Zugriff am 12.05.2025 unter https://sari-dashboard.at
• 10 Haskell L, Tavender EJ, Wilson CL. et al Effectiveness of targeted interventions on treatment of infants with bronchiolitis: A randomized clinical trial. JAMA Pediatr 2021; 175: 797-806
• 11 NICE. NICE-Guidline – Bronchiolitis in children: Diagnosis and management. Zugriff am 12.05.2025 unter t1p.de/y1buq
• 12 O’Brien S, Borland ML, Cotterell E. et al Australasian bronchiolitis guideline. J Paediatr Child Health 2019; 55: 42-53
• 13 Ralston SL, Lieberthal AS, Meissner HC. et al Clinical practice guideline: The diagnosis, management, and prevention of bronchiolitis. Pediatrics 2014; 134: e1474-e1502
• 14 Schneider J, Sweberg T.. Acute respiratory failure. Crit Care Clin 2013; 29: 167-183
• 15 Marlow JA, Kalburgi S, Gupta V. et al Perspectives of health care personnel on the benefits of bronchiolitis interventions. Pediatrics 2023; 151
• 16 Whelan B.. Nurse role in RSV management. Early Hum Dev 2012; 88 Suppl 2 S29-S30
• 17 Elks M, Young J, Kearney L. et al The impact of an autonomous nurse-led high-flow nasal cannula oxygen protocol on clinical outcomes of infants with bronchiolitis. J Clin Nurs 2023; 32: 4719-4729
• 18 Breakell R, Thorndyke B, Clennett J. et al Reducing unnecessary chest X-rays, antibiotics and bronchodilators through implementation of the NICE bronchiolitis guideline. Eur J Pediatr 2018; 177: 47-51
• 19 Haskell L, Tavender EJ, O’Brien S. et al Can targeted interventions change the factors influencing variation in management of infants with bronchiolitis? A survey of Australian and New Zealand clinicians: A paediatric research in emergency departments international collaborative (PREDICT) study. J Paediatr Child Health 2022; 58: 302-311
• 20 Lavilledieu D, Abassi H, Mercier G. et al Implementation of an organizational infrastructure paediatric plan adapted to bronchiolitis epidemics. J Infect Public Health 2020; 13: 167-172
• 21 Mittal V, Darnell C, Walsh B. et al Inpatient bronchiolitis guideline implementation and resource utilization. Pediatrics 2014; 133: e730-e737
• 22 Pinto JM, Schairer JL, Petrova A.. Comparative effectiveness of implementation of a nursing-driven protocol in reducing bronchodilator utilization for hospitalized children with bronchiolitis. J Eval Clin Pract 2014; 20: 267-272
• 23 Tarantino L, Goodrich N, Kerns E. et al Is implementation of a hospital pathway for high-flow nasal cannula initiation and weaning associated with reduced high-flow duration in bronchiolitis?. Pediatr Pulmonol 2022; 57: 2971-2980
• 24 Franklin D, Babl FE, Schlapbach LJ. et al A randomized trial of high-flow oxygen therapy in infants with bronchiolitis. N Engl J Med 2018; 378: 1121-1131
• 25 Huang JX, Colwell B, Vadlaputi P. et al Protocol-driven initiation and weaning of high-flow nasal cannula for patients with bronchiolitis: A quality improvement initiative. Pediatr Crit Care Med 2023; 24: 112-122
• 26 Higuchi KS, Davies B, Ploeg J.. Sustaining guideline implementation: A multisite perspective on activities, challenges and supports. J Clin Nurs 2017; 26: 4413-4424
• 27 Buckwalter KC, Cullen L, Hanrahan K. et al Iowa model of evidence-based practice: Revisions and validation. Worldviews Evid Based Nurs 2017; 14: 175-182